Pfizer Gets Green Light to Allow 12-Year-Olds in Coronavirus Vaccine Trials

>>Follow Matzav On Whatsapp!<<

Pharmaceutical company Pfizer said it has gotten approval from the Food and Drug Administration to allow children as young as 12 years old to take part in coronavirus trials, according to The Hill.

The move comes after health officials requested the expansion to make sure a safe vaccine was developed for children.

Before this expansion, people younger than age 16 weren’t involved in U.S. vaccine trials.

Read more at NEWSMAX.



  1. Why do children need to get this vaccine? The goal of this vaccine is NOT to prevent infection but just to lessen symptoms – but children don’t get severe symptoms to begin with. PARENTS, BEWARE!
    Covid-19 Vaccine Protocols Reveal That Trials Are Designed To Succeed

    By William Haseltine (Haseltine was a professor at Harvard Medical School where he founded two research departments on cancer and HIV/AIDS)
    Prevention of infection is not a criterion for success for any of these vaccines. In fact, their endpoints all require confirmed infections and all those they will include in the analysis for success, the only difference being the severity of symptoms between the vaccinated and unvaccinated. Measuring differences amongst only those infected by SARS-CoV-2 underscores the implicit conclusion that the vaccines are not expected to prevent infection, only modify symptoms of those infected….

    We all expect an effective vaccine to prevent serious illness if infected. Three of the vaccine protocols—Moderna, Pfizer, and AstraZeneca—do not require that their vaccine prevent serious disease only that they prevent moderate symptoms which may be as mild as cough, or headache….

    These protocols do not emphasize the most important ramifications of Covid-19 that people are most interested in preventing: overall infection, hospitalization, and death. It boggles the mind and defies common sense that the National Institute of Health, the Center for Disease Control, the National Institute of Allergy and Infectious Disease, and the rest would consider the approval of a vaccine that would be distributed to hundreds of millions on such slender threads of success.


Please enter your comment!
Please enter your name here